唑来磷酸治疗乳腺癌骨转移的临床研究(3)
第1页 |
参见附件。
[3] Berenson JR. Zoledronic acid in cancer patients with bone metastases:Results of phase I andⅡtrails[J]. Semin Oncol,2011,28(6):25-34.
[4] 刘鹏熙,周瑞芳,许锐,等. 唑来膦酸与帕米磷酸二钠治疗乳腺癌骨转移性疼痛的近期疗效观察[J]. 中华乳腺病杂志,2008,2(4):402-406.
[5] King A E,Um land EM. Osteonecrosis of the jaw in patients Receiving Intravenous or ora l bisphosphonates[J]. Pharm acotherapy,2008,28(4):667-677.
[6] Rove KO,Crawford ED. Metastatic cancer in solid tumors and clinical outcome: Skeletal-related events[J]. Oncology(Williston Park),2009,23(14):21-27.
[7] Ricciardi S,De Marinis F. Treatment of bone metastases in lung cancer:The actual role of zoledronic acid[J]. Rev Recent Clin Trials,2009,4(3):205-211.
[8] Fitch M,Maxwell C,Ryan C,et al. Bone metastases from advanced cancers:Clinical implications and treatment options[J]. Clin J Oncol Nurs,2009,13(6):701-710.
[9] 董梅,冯奉仪,张阳,等. 唑来膦酸治疗实体瘤骨转移或多发性骨髓瘤中重度骨痛的Ⅲ期临床研究[J]. 中华肿瘤杂志,2008,30(3):215-220.
[10] 夏环玲,梁彬彬,杨京华. 唑来磷酸治疗恶性肿瘤骨转移临床观察[J]. 中国现代药物应用,2010,4(7):147-148.
[11] 任军,邸立军,冯奉仪,等. 国产唑来膦酸(博来宁)与帕米膦酸二钠(博宁)治疗癌性骨痛随机双盲双模拟多中心Ⅱ期临床研究[J]. 中国肿瘤临床,2006,33(20):1169-1172.
(收稿日期:2013-11-04)
您现在查看是摘要介绍页,详见PDF附件。